Advertisement
Sigma-Aldrich
Sigma-Aldrich

The Scientist

» biotechnology and immunology

Most Recent

image: FDA Approves Prosthetic Arm

FDA Approves Prosthetic Arm

By | May 14, 2014

The agency OKs the first prosthetic arm controlled by neural signals from the user’s muscles.

0 Comments

image: Long-Distance Call

Long-Distance Call

By | May 1, 2014

Neurons may use interferon signals transmitted over great distances to fend off viral infection.

0 Comments

image: The Promise of Nanomedicine

The Promise of Nanomedicine

By | April 8, 2014

At AACR, scientists discuss the growing interest in nanotechnology and how it can be used to study, diagnose, and treat cancer.

0 Comments

image: DARPA Puts Biotech at the Fore

DARPA Puts Biotech at the Fore

By | April 4, 2014

The U.S. Department of Defense is solidifying its focus on the life sciences with a new division of biotechnology.  

0 Comments

image: Commander of an Immune Flotilla

Commander of an Immune Flotilla

By | April 1, 2014

With much of his early career dictated by US Navy interests, Carl June drew inspiration from malaria, bone marrow transplantation, and HIV in his roundabout path to a breakthrough in cancer immunotherapy.

1 Comment

image: Deploying the Body’s Army

Deploying the Body’s Army

By | April 1, 2014

Using patients’ own immune systems to fight cancer

3 Comments

image: Vitamin A’s Influence on Immunity

Vitamin A’s Influence on Immunity

By | March 19, 2014

Exposure to vitamin A in the womb influences immune system development and lifelong ability to fight infections, a mouse study shows. 

1 Comment

image: Biotech Superstar Dies

Biotech Superstar Dies

By | March 7, 2014

Alejandro Zaffaroni, who launched companies that developed birth control pills, microarrays, and transdermal drug patches, has died at age 91.  

0 Comments

image: Opinion: Translational Biotechnology

Opinion: Translational Biotechnology

By | February 17, 2014

Regulators must consider both the promise and potential pitfalls of new technologies when determining whether to move them into clinical trials.

0 Comments

image: Biotech, Meet Crowdfunding

Biotech, Meet Crowdfunding

By | February 13, 2014

Proposed regulations from the US Securities and Exchange Commission have the biotech industry tuning in to the roar of the crowd.  

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
R&D Systems
R&D Systems
Advertisement
PITTCON
PITTCON
Life Technologies